Page 1

Immunic THERAPEUTICS Discovery of IMU - 856 , a Selective Sirtuin 6 Modulator with Novel Binding Characteristics for Gastrointestinal Disease Treatment Dr. Christian Gege NASDAQ : IMUX | September / 08 / 2026 | EFMC Medicinal Chemistry 2026 - Basel